RT @montypal: Great data by @PGrivasMDPhD @DrChoueiri on the utilization of COVID-19 TXs & clinical outcomes among pts w/ cancer. Findings…
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort study [Jul 22, 2020] Rivera @peters_solange et al. @gary_lyman @hemoncwarner @CD_AACR https://t.co/v7lINKLnZi #AACRCov
RT @montypal: Great data by @PGrivasMDPhD @DrChoueiri on the utilization of COVID-19 TXs & clinical outcomes among pts w/ cancer. Findings…
RT @montypal: Great data by @PGrivasMDPhD @DrChoueiri on the utilization of COVID-19 TXs & clinical outcomes among pts w/ cancer. Findings…
Great data by @PGrivasMDPhD @DrChoueiri on the utilization of COVID-19 TXs & clinical outcomes among pts w/ cancer. Findings add to the understanding of patterns of care for pts w/ cancer & COVID-19 & support evaluation of new TXs through contr
Utilization of #COVID19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC19) cohort study @AACR @ASCOPost https://t.co/Aq3a1itSET
Well done CCC19 for getting their second major paper published! >2,000 cancer patients analyses, giving the power for useful analyses @GlopesMd
RT @Ecquis: Proud to be part of the best thing to originate from a Tweet @COVID19nCCC , ever! @brian_rini @rubinstein_md @l_schapira @dr_as…
RT @Ecquis: Proud to be part of the best thing to originate from a Tweet @COVID19nCCC , ever! @brian_rini @rubinstein_md @l_schapira @dr_as…
RT @Ecquis: Proud to be part of the best thing to originate from a Tweet @COVID19nCCC , ever! @brian_rini @rubinstein_md @l_schapira @dr_as…
RT @JTrentMDPhD: Congratulations @GlopesMd : Utilization of #COVID-19 treatments and clinical outcomes among patients with cancer: A COVI…
RT @JTrentMDPhD: Congratulations @GlopesMd : Utilization of #COVID-19 treatments and clinical outcomes among patients with cancer: A COVI…
Congratulations @GlopesMd : Utilization of #COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and #Cancer Consortium cohort study | @cancerdisc https://t.co/RKKnvyMTsp
Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort study [Jul 22, 2020] Rivera @peters_solange et al. @gary_lyman @hemoncwarner @CD_AACR https://t.co/enSLlL2TPt #AACRCov
RT @mtmdphd: Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC19)…
RT @TiansterZhang: Proud to have contributed to the @COVID19nCCC data @DukeGUCancer, published in @CD_AACR yesterday. Learning more about p…
RT @mtmdphd: Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC19)…
RT @COVID19nCCC: Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC…
RT @ErinGillaspie: Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (C…
RT @arkhaki: Out today in @cancerdisc - https://t.co/Mijii8IC24 - most recent analysis from @COVID19nCCC #CCC19 See tweetorial from @hemon…
Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC19) cohort study [Jul 22, 2020] Rivera et al. @CD_AACR https://t.co/enSLlL2TPt #CCC19 #AACRCovid #COVID19 #COVID19nCancer @COVID19nCCC
RT @TiansterZhang: Proud to have contributed to the @COVID19nCCC data @DukeGUCancer, published in @CD_AACR yesterday. Learning more about p…
RT @COVID19nCCC: Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC…
RT @JBarnholtzSloan: @COVID19nCCC shows that high quality observational studies have an important role to help provide evidence to…
RT @rubinstein_md: See the latest analysis of #CCC19 data published in @CD_AACR today sheds light on utilization and outcomes associated wi…
RT @TiansterZhang: Proud to have contributed to the @COVID19nCCC data @DukeGUCancer, published in @CD_AACR yesterday. Learning more about p…
RT @rubinstein_md: See the latest analysis of #CCC19 data published in @CD_AACR today sheds light on utilization and outcomes associated wi…
RT @TiansterZhang: Proud to have contributed to the @COVID19nCCC data @DukeGUCancer, published in @CD_AACR yesterday. Learning more about p…
RT @shilpaonc: Congrats to the entire @COVID19nCCC team! Proud to be part on this tremendous effort! @CleClinicMD @n8pennell @NicoleKuderer…
Take a look at this great Tweetorial from @hemoncwarner on the new @COVID19nCCC paper in @CD_AACR that sheds light on care for cancer patients with #COVID19. #COVID19nCancer Read the study: https://t.co/T8jIgWWpj1
Very proud of #RogelCancer contributions to this effort!
RT @ErinGillaspie: Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (C…
Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC19) cohort study https://t.co/irb3LTxMzq
RT @COVID19nCCC: Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC…
Remdesivir was linked with a lower mortality rate when compared to patients receiving any other potential #COVID19 treatment. Black patients were half as likely to receive #remdesivir as white patients #coronavirus https://t.co/7Wu8LXaMal
RT @TiansterZhang: Proud to have contributed to the @COVID19nCCC data @DukeGUCancer, published in @CD_AACR yesterday. Learning more about p…
RT @TiansterZhang: Proud to have contributed to the @COVID19nCCC data @DukeGUCancer, published in @CD_AACR yesterday. Learning more about p…
RT @TiansterZhang: Proud to have contributed to the @COVID19nCCC data @DukeGUCancer, published in @CD_AACR yesterday. Learning more about p…
RT @ZiadBakouny: Important study just out in @CD_AACR from the @COVID19nCCC on patterns of care for COVID-19 and clinical outcomes in patie…
Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC19) cohort study [Jul 22, 2020] Rivera et al. @CD_AACR https://t.co/v7lINKLnZi #CCC19 #AACRCovid #COVID19 #COVID19nCancer https://t.co
RT @BMT_DrNemecek: Amazing team effort! @hemoncwarner @COVID19nCCC https://t.co/TONwSLjm1K
RT @TiansterZhang: Proud to have contributed to the @COVID19nCCC data @DukeGUCancer, published in @CD_AACR yesterday. Learning more about p…
RT @JBarnholtzSloan: So honored to be a part of this collaborative team! @COVID19nCCC #CCC19 @caseccc @UHhospitals @ClevelandClinic
RT @ElizSMcKenna: Just online NOW in @CD_AACR to concide with the last day of #AACRCovid – Utilization of #COVID-19 treatments and clinical…
So honored to be a part of this collaborative team! @COVID19nCCC #CCC19 @caseccc @UHhospitals @ClevelandClinic
RT @arkhaki: Out today in @cancerdisc - https://t.co/Mijii8IC24 - most recent analysis from @COVID19nCCC #CCC19 See tweetorial from @hemon…
RT @Ecquis: Proud to be part of the best thing to originate from a Tweet @COVID19nCCC , ever! @brian_rini @rubinstein_md @l_schapira @dr_as…
RT @gary_lyman: Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC1…
RT @TiansterZhang: Proud to have contributed to the @COVID19nCCC data @DukeGUCancer, published in @CD_AACR yesterday. Learning more about p…
RT @YLeyfman: Congratulations @COVID19nCCC on this cohesive publication that succinctly summarizes treatment and clinical outcomes amongst…
Proud to have contributed to the @COVID19nCCC data @DukeGUCancer, published in @CD_AACR yesterday. Learning more about patients with cancer and #COVID19. Remdesivir still the most promising treatment. https://t.co/8H0ASvJcdg
RT @ZiadBakouny: Important study just out in @CD_AACR from the @COVID19nCCC on patterns of care for COVID-19 and clinical outcomes in patie…
RT @COVID19nCCC: Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC…
RT @rubinstein_md: See the latest analysis of #CCC19 data published in @CD_AACR today sheds light on utilization and outcomes associated wi…
RT @ElizSMcKenna: Just online NOW in @CD_AACR to concide with the last day of #AACRCovid – Utilization of #COVID-19 treatments and clinical…
RT @ZiadBakouny: Important study just out in @CD_AACR from the @COVID19nCCC on patterns of care for COVID-19 and clinical outcomes in patie…
RT @gary_lyman: Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC1…
Congratulations @COVID19nCCC on this cohesive publication that succinctly summarizes treatment and clinical outcomes amongst cancer patients with #COVID19. Teamwork makes the dream work especially with such a prolific cohort of superstars. #inspired #AACRC
RT @saramatarmd: Another great publication by the fantastic @COVID19nCCC
RT @rubinstein_md: See the latest analysis of #CCC19 data published in @CD_AACR today sheds light on utilization and outcomes associated wi…
RT @saramatarmd: Another great publication by the fantastic @COVID19nCCC
Another great publication by the fantastic @COVID19nCCC
RT @Ecquis: Proud to be part of the best thing to originate from a Tweet @COVID19nCCC , ever! @brian_rini @rubinstein_md @l_schapira @dr_as…
RT @ZiadBakouny: Important study just out in @CD_AACR from the @COVID19nCCC on patterns of care for COVID-19 and clinical outcomes in patie…
RT @gary_lyman: Thanks @arkhaki for all you do for our effort @PGrivasMDPhD @NicoleKuderer @hemoncwarner @Ecquis